Kailera Therapeutics Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Kailera Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $42.65. The average 1-year stock price forecast is 118.16% higher than the current stock price, while the lowest is $30 (+53.45%) and the highest is $57 (+191.56%).

Price Target: $42.65 (+118.16%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$30	$42.65	$42.25	$57
Change	+53.45%	+118.16%	+116.11%	+191.56%

Analyst Ratings

The average analyst rating for Kailera Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	May '26
Strong Buy	1
Buy	3
Hold	0
Sell	0
Strong Sell	0
Total	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Risinger Leerink Partners	Leerink Partners	Buy Initiates $36	Buy	Initiates	$36	+84.14%	May 12, 2026
Roger Song Jefferies	Jefferies	Strong Buy Initiates $48	Strong Buy	Initiates	$48	+145.52%	May 12, 2026
Umer Raffat Evercore ISI Group	Evercore ISI Group	Buy Initiates n/a	Buy	Initiates	n/a	n/a	May 12, 2026
Hardik Parikh JP Morgan	JP Morgan	Buy Initiates $30	Buy	Initiates	$30	+53.45%	May 12, 2026

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.